GILD vs OWL · P/E 18, rev $7.80B vs P/E 79, rev $275.1M
Gilead Sciences Inc (GILD) versus Blue Owl Capital Inc (OWL) — a side-by-side from cached financials, not a winner call.
Gilead Sciences Inc (GILD) is a drug manufacturers - general company listed on US.
Blue Owl Capital Inc (OWL) is a asset management company listed on NYSE.
Latest reported GILD revenue for 2026-06-30 was $7.80B. Net income was -$10.50B. Revenue was up 12.1% from 2026-03-31 to 2026-06-30. GILD currently screens at market cap $160.15B and trailing P/E 17.5.
Latest reported OWL revenue for 2026-06-30 was $275.1M. Net income was $26.9M. Revenue was up 99.3% from 2026-03-31 to 2026-06-30. OWL currently screens at market cap $14.82B and trailing P/E 79.2.
GILD currently screens at market cap $160.15B and trailing P/E 17.5. OWL currently screens at market cap $14.82B and trailing P/E 79.2.
Not investment advice. Open the GILD and OWL stock pages for the full models.
Not investment advice.